BeOne Medicines ONC
NASDAQ ONC
$359.97 -5.03 (-1.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Income from Non-Controlling Interests (2017 - 2020)

BeOne Medicines' (ONC) quarterly Income from Non-Controlling Interests came in at $96000.0 in Q4 2020, down 42.17% year-over-year from $166000.0 in Q1 2020, and up 106.89% quarter-over-quarter from -$1.4 million in Q3 2020.

Analysis

BeOne Medicines (ONC) Income from Non-Controlling Interests (2017 - 2020) Analysis & Trends

BeOne Medicines (ONC) has reported Income from Non-Controlling Interests for 4 consecutive years, with $96000.0 the latest figure, recorded in Q4 2020.

  • On a quarterly basis, Income from Non-Controlling Interests fell 42.17% year-over-year to $96000.0 in Q4 2020; TTM through Sep 2021 was $96000.0, a 102.71% increase from a year earlier, with the FY2020 full-year figure at -$3.6 million, down 85.49% from the prior year.
  • Income from Non-Controlling Interests was $96000.0 for Q4 2020 at BeOne Medicines, up from -$1.4 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $1.5 million in Q4 2018 and troughed at -$1.4 million in Q3 2020.
  • A 4-year average of -$401666.7 and a median of -$429000.0 in 2019 frame the typical range for Income from Non-Controlling Interests.
  • The widest YoY moves for Income from Non-Controlling Interests: up 3493.02% in 2018, down 513.33% in 2018.
  • Over 4 years, Income from Non-Controlling Interests stood at $43000.0 in 2017, then jumped by 3493.02% to $1.5 million in 2018, then tumbled by 89.26% to $166000.0 in 2019, then slumped by 42.17% to $96000.0 in 2020.
  • The last three Income from Non-Controlling Interests figures came in at $96000.0 (Q4 2020), -$1.4 million (Q3 2020), and -$1.1 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 3.00 Mn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -2.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -7.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 1.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 10.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 BeOne Medicines 41.25 Bn 36.15 Bn 1.53 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 96,000.00
Sep 30, 2020 -1.39 Mn
Jun 30, 2020 -1.12 Mn
Mar 31, 2020 -1.20 Mn
Dec 31, 2019 166,000.00
Sep 30, 2019 -1.30 Mn
Jun 30, 2019 -384,000.00
Mar 31, 2019 -429,000.00
Dec 31, 2018 1.55 Mn
Sep 30, 2018 -461,000.00
Jun 30, 2018 -828,000.00
Mar 31, 2018 -520,000.00
Dec 31, 2017 43,000.00
Sep 30, 2017 -102,000.00
Jun 30, 2017 -135,000.00
API Access

BeOne Medicines Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ONC&period=max&api_key=YOUR_API_KEY